Beyond Air® Schedules Fiscal Year 2021 Financial Results Conference Call and Webcast
May 25, 2021
Beyond Air® Strengthens Commercial Leadership Team with Appointments of Head of Sales and Head of Marketing
May 20, 2021
Beyond Air® Presents Data in Hospitalized Patients with Viral Lung Infections (including COVID-19) from LungFit® PRO Programs at ATS 2021
May 13, 2021
Beyond Air® Appoints Peter Senior as Director of Business Development
May 3, 2021
Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in May 2021
April 14, 2021
Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in March 2021
March 1, 2021
Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease
February 16, 2021
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update
February 9, 2021
Beyond Air® Schedules Third Fiscal Quarter 2021 Financial Results Conference Call and Webcast
January 15, 2021
Beyond Air® Initiates Patient Screening for LungFit™ GO Pilot Study for At-Home, Self-Administration of Inhaled Nitric Oxide in Nontuberculous Mycobacteria Lung Disease
December 7, 2020

Sign up for updates from Beyond Air, Inc.

Unsubscribe from all email communications. Unsubscribe